The complexities and versatility of the RAS-to-ERK signalling system in normal and cancer cells.
about
Clinical responses to ERK inhibition in BRAFV600E-mutant colorectal cancer predicted using a computational model.Cancer cell redirection biomarker discovery using a mutual information approachLong noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways.Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub.Two is better than one; toward a rational design of combinatorial therapy.MiR-148a impairs Ras/ERK signaling in B lymphocytes by targeting SOS proteinsSustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma.Characterisation of HRas local signal transduction networks using engineered site-specific exchange factors.Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis-A connection to licensing nodes.Dynamics and control of the ERK signaling pathway: Sensitivity, bistability, and oscillations.[Mathematical modeling: an essential tool for the study of therapeutic targeting in solid tumors].The synergistic effect of propofol and ulinastatin suppressed the viability of the human lung adenocarcinoma epithelial A549 cell line
P2860
Q33767369-1076931B-F0FE-47BD-838D-11F5A28C73F8Q33778794-C6C1FCAD-8E10-4229-B2A7-E09460E77F09Q38736586-B69DB98F-2278-4D8E-9D22-B4B9D6745BF7Q38891078-3D670CB2-521A-4446-9ACD-38A830FC6666Q38926952-9AC2B6D1-1C49-4C7F-8E4B-33D915FF8620Q41346414-8C91F306-BE5B-4709-ACAB-3FA11A930CB9Q48164741-CB0927EF-BE5E-4172-8ADD-E13A7ABEFEDFQ48238039-7B7D6189-D326-49BC-937D-502C97E4CABEQ51049205-931C7E00-C58C-4AAE-A09E-5DC69F7D34BCQ52328132-58E6B601-8017-4E84-AC04-2E58CD7D333EQ52407643-65CB1E1D-0862-4E44-8B14-57E33D6A1E41Q58794878-1BDC1740-3BFD-4F59-8C27-F61AD84D4693
P2860
The complexities and versatility of the RAS-to-ERK signalling system in normal and cancer cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The complexities and versatili ...... em in normal and cancer cells.
@en
type
label
The complexities and versatili ...... em in normal and cancer cells.
@en
prefLabel
The complexities and versatili ...... em in normal and cancer cells.
@en
P2093
P50
P1476
The complexities and versatili ...... em in normal and cancer cells.
@en
P2093
Boris N Kholodenko
David Matallanas
Jens Rauch
Oleksii S Rukhlenko
P304
P356
10.1016/J.SEMCDB.2016.06.011
P577
2016-06-24T00:00:00Z